Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot O60282: Variant p.Glu237Lys

Kinesin heavy chain isoform 5C
Gene: KIF5C
Feedback?
Variant information Variant position: help 237 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Glutamate (E) to Lysine (K) at position 237 (E237K, p.Glu237Lys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and acidic (E) to large size and basic (K) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In CDCBM2; the mutation results in a significant decrease of excitatory post-synaptic currents when expressed in cultured primary hippocampal neurons; decreased localization to distal regions of dendrites; accumulates in dendrite cell body. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 237 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 957 The length of the canonical sequence.
Location on the sequence: help NVETEKKLSGKLYLVDLAGS E KVSKTGAEGAVLDEAKNINK The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         NVETEKKLSGKLYLVDLAGSEKVSKTGAEGAVLDEAKNINK

Mouse                         NVETEKKLSGKLYLVDLAGSEKVSKTGAEGAVLDEAKNINK

Rat                           NVETEKKLSGKLYLVDLAGSEKVSKTGAEGAVLDEAKNINK
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 957 Kinesin heavy chain isoform 5C
Domain 8 – 327 Kinesin motor
Region 174 – 315 Microtubule-binding
Alternative sequence 233 – 238 LAGSEK -> MATYIH. In isoform 2.



Literature citations
Involvement of the kinesin family members KIF4A and KIF5C in intellectual disability and synaptic function.
Willemsen M.H.; Ba W.; Wissink-Lindhout W.M.; de Brouwer A.P.; Haas S.A.; Bienek M.; Hu H.; Vissers L.E.; van Bokhoven H.; Kalscheuer V.; Nadif Kasri N.; Kleefstra T.;
J. Med. Genet. 51:487-494(2014)
Cited for: FUNCTION; SUBCELLULAR LOCATION; VARIANT CDCBM2 LYS-237; CHARACTERIZATION OF VARIANT CDCBM2 LYS-237; Diagnostic exome sequencing in persons with severe intellectual disability.
de Ligt J.; Willemsen M.H.; van Bon B.W.; Kleefstra T.; Yntema H.G.; Kroes T.; Vulto-van Silfhout A.T.; Koolen D.A.; de Vries P.; Gilissen C.; del Rosario M.; Hoischen A.; Scheffer H.; de Vries B.B.; Brunner H.G.; Veltman J.A.; Vissers L.E.;
N. Engl. J. Med. 367:1921-1929(2012)
Cited for: VARIANT CDCBM2 LYS-237; Mutations of KIF5C cause a neurodevelopmental disorder of infantile-onset epilepsy, absent language, and distinctive malformations of cortical development.
Michels S.; Foss K.; Park K.; Golden-Grant K.; Saneto R.; Lopez J.; Mirzaa G.M.;
Am. J. Med. Genet. A 173:3127-3131(2017)
Cited for: VARIANT CDCBM2 LYS-237;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.